Foresite Capital Management IV, LLC Diversified Active

Name: Foresite Capital Management IV, LLC Q4 2018 13F Filing | 13F Explorer
Creator: Foresite Capital Management IV, LLC
Published: 2019-02-13

Location: West Hollywood, CA

CIK: 0001704132 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 13, 2019

Total Value: $218M (100.0% shares, 0.0% debt)

Holdings (18)

— Biohaven Pharmaceutical Holding Company Ltd. 14.5%

Value $31.65M Shares 855,900 Est. Cost $26.07 Unrealized —

INSM Insmed Incorporated 11.9%

Value $25.94M Shares 1,977,236 Est. Cost $26.83 Unrealized -40.5%

— Myokardia, Inc. 10.9%

Value $23.78M Shares 486,624 Est. Cost $45.40 Unrealized —

— CymaBay Therapeutics, Inc. 9.5%

Value $20.71M Shares 2,631,258 Est. Cost $8.89 Unrealized —

— Immunomedics, Inc. 7.9%

Value $17.2M Shares 1,205,363 Est. Cost $17.13 Unrealized —

ASND Ascendis Pharma A/S 7.1%

Value $15.38M Shares 245,424 Est. Cost $40.06 Unrealized —

REPL Replimune Group, Inc. 5.6%

Value $12.3M Shares 1,229,656 Est. Cost $17.53 Unrealized -22.9%

RYTM Rhythm Pharmaceuticals, Inc. 4.9%

Value $10.75M Shares 400,000 Est. Cost $27.09 Unrealized +2.0%

— OptiNose, Inc. 4.9%

Value $10.59M Shares 1,708,545 Est. Cost $17.42 Unrealized —

— Orchard Therapeutics PLC 4.8%

Value $10.51M Shares 668,361 Est. Cost $15.73 Unrealized —

— Aerie Pharmaceuticals, Inc. 4.3%

Value $9.452M Shares 261,823 Est. Cost $36.10 Unrealized —

ABUS Arbutus Biopharma Corporation 2.8%

Value $6.06M Shares 1,582,275 Est. Cost $5.62 Unrealized -12.3%

— Eidos Therapeutics, Inc. 2.7%

Value $5.941M Shares 431,781 Est. Cost $14.82 Unrealized —

ACRS Aclaris Therapeutics, Inc. 2.5%

Value $5.529M Shares 748,132 Est. Cost $18.71 Unrealized -44.9%

— Portola Pharmaceuticals, Inc. 2.2%

Value $4.88M Shares 250,000 Est. Cost $19.52 Unrealized —

SIBN SI-BONE, Inc. 2.0%

Value $4.295M Shares 205,621 Est. Cost $18.92 Unrealized 0.0%

— Kiniksa Pharmaceuticals, Ltd. 0.8%

Value $1.796M Shares 63,922 Est. Cost $17.35 Unrealized —

CYTK Cytokinetics Incorporated 0.5%

Value $1.107M Shares 175,148 Est. Cost $7.34 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Biohaven Pharmaceutical Holding Company Ltd.	855,900	$31.65M	14.5%	$26.07	—	COM	G11196105
INSM	Insmed Incorporated	1,977,236	$25.94M	11.9%	$26.83	-40.5%	COM	457669307
—	Myokardia, Inc.	486,624	$23.78M	10.9%	$45.40	—	COM	62857M105
—	CymaBay Therapeutics, Inc.	2,631,258	$20.71M	9.5%	$8.89	—	COM	23257D103
—	Immunomedics, Inc.	1,205,363	$17.2M	7.9%	$17.13	—	COM	452907108
ASND	Ascendis Pharma A/S	245,424	$15.38M	7.1%	$40.06	—	SPONSORED ADR	04351P101
REPL	Replimune Group, Inc.	1,229,656	$12.3M	5.6%	$17.53	-22.9%	COM	76029N106
RYTM	Rhythm Pharmaceuticals, Inc.	400,000	$10.75M	4.9%	$27.09	+2.0%	COM	76243J105
—	OptiNose, Inc.	1,708,545	$10.59M	4.9%	$17.42	—	COM	68404V100
—	Orchard Therapeutics PLC	668,361	$10.51M	4.8%	$15.73	—	ADS	68570P101
—	Aerie Pharmaceuticals, Inc.	261,823	$9.452M	4.3%	$36.10	—	COM	00771V108
ABUS	Arbutus Biopharma Corporation	1,582,275	$6.06M	2.8%	$5.62	-12.3%	COM	03879J100
—	Eidos Therapeutics, Inc.	431,781	$5.941M	2.7%	$14.82	—	COM	28249H104
ACRS	Aclaris Therapeutics, Inc.	748,132	$5.529M	2.5%	$18.71	-44.9%	COM	00461U105
—	Portola Pharmaceuticals, Inc.	250,000	$4.88M	2.2%	$19.52	—	COM	737010108
SIBN	SI-BONE, Inc.	205,621	$4.295M	2.0%	$18.92	0.0%	COM	825704109
—	Kiniksa Pharmaceuticals, Ltd.	63,922	$1.796M	0.8%	$17.35	—	Class A Common	G5269C101
CYTK	Cytokinetics Incorporated	175,148	$1.107M	0.5%	$7.34	0.0%	COM NEW	23282W605